Charles A L Rareshide
Overview
Explore the profile of Charles A L Rareshide including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao J, Sun C, Yan X, Patel M, Small D, Isenberg W, et al.
Am J Med Qual
. 2023 Apr;
38(3):129-136.
PMID: 37017283
Peer comparison feedback is a promising strategy for reducing opioid prescribing and opioid-related harms. Such comparisons may be particularly impactful among underestimating clinicians who do not perceive themselves as high...
2.
Manz C, Zhang Y, Chen K, Long Q, Small D, Evans C, et al.
JAMA Oncol
. 2023 Jan;
9(3):414-418.
PMID: 36633868
Importance: Serious illness conversations (SICs) between oncology clinicians and patients are associated with improved quality of life and may reduce aggressive end-of-life care. However, most patients with cancer die without...
3.
Mehta S, Torgersen J, Small D, Mallozzi C, McGreevey 3rd J, Rareshide C, et al.
JAMA Netw Open
. 2022 Mar;
5(3):e222427.
PMID: 35297973
Importance: Hepatitis C virus (HCV) screening has been recommended for patients born between 1945 and 1965, but rates remain low. Objective: To evaluate whether a default order within the admission...
4.
Navathe A, Liao J, Yan X, Delgado M, Isenberg W, Landa H, et al.
Health Aff (Millwood)
. 2022 Mar;
41(3):424-433.
PMID: 35254932
An initial opioid prescription with a greater number of pills is associated with a greater risk for future long-term opioid use, yet few interventions have reliably influenced individual clinicians' prescribing....
5.
Patel M, Bachireddy C, Small D, Harrison J, Harrington T, Oon A, et al.
JAMA Cardiol
. 2021 Sep;
6(12):1387-1396.
PMID: 34468691
Importance: Health promotion efforts commonly communicate goals for healthy behavior, but the best way to design goal setting among high-risk patients has not been well examined. Objective: To test the...
6.
Patel M, Small D, Harrison J, Hilbert V, Fortunato M, Oon A, et al.
JAMA Netw Open
. 2021 May;
4(5):e2110255.
PMID: 34028550
Importance: Gamification is increasingly being used to promote healthy behaviors. However, it has not been well tested among patients with chronic conditions and over longer durations. Objective: To test the...
7.
Greysen S, Changolkar S, Small D, Reale C, Rareshide C, Mercede A, et al.
JAMA Netw Open
. 2021 Mar;
4(3):e210952.
PMID: 33760089
Importance: Hospitalization is associated with decreased mobility and functional decline. Behaviorally designed gamification can increase mobility in community settings but has not been tested among patients at risk for functional...
8.
Oakes A, Adusumalli S, Snider C, Rareshide C, Patel M
J Am Coll Cardiol
. 2021 Feb;
77(5):661-662.
PMID: 33538261
No abstract available.
9.
Adusumalli S, Jolly E, Chokshi N, Gitelman Y, Rareshide C, Kolansky D, et al.
JAMA Netw Open
. 2021 Jan;
4(1):e2033472.
PMID: 33443579
No abstract available.
10.
Manz C, Parikh R, Small D, Evans C, Chivers C, Regli S, et al.
JAMA Oncol
. 2020 Oct;
6(12):e204759.
PMID: 33057696
Importance: Serious illness conversations (SICs) are structured conversations between clinicians and patients about prognosis, treatment goals, and end-of-life preferences. Interventions that increase the rate of SICs between oncology clinicians and...